40 Participants NeededMy employer runs this trial

Cognitive Rehabilitation for Brain Cancer Survivors

RS
Overseen ByRanganatha Sitaram
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: St. Jude Children's Research Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will evaluate a new way to help childhood medulloblastoma survivors improve their thinking and memory skills. Many survivors experience long term challenges with attention and working memory because of the tumor and its treatments. The study uses real time neuroimaging technologies such as real time functional magnetic resonance imaging (rt-fMRI) and real time functional near infrared spectroscopy (rt-fNIRS) make it possible to monitor and display a participant's brain activity as it occurs. Neurofeedback uses this activity to provide individuals with immediate visual information about how specific brain regions are functioning, potentially enabling them to learn strategies to modulate or improve brain activity linked to thinking skills.

Participants are randomly assigned to one of two groups. One group receives feedback from a brain area involved in working memory, and the other receives feedback from a different brain region as a comparison. Over three visits, participants complete brain scans, neurofeedback sessions, and thinking and memory tests.

The main goal is to see if this type of brain training is practical, safe, and comfortable for survivors. The study also looks at whether the training may help improve brain activity and working memory performance.

Primary Objective(s):

• To evaluate the feasibility of real time Hemo-NFB neurofeedback training in medulloblastoma survivors.

Secondary Objective(s):

• To estimate the initial efficacy of Hemo-NFB neurofeedback to up-regulate the activity of the dorsolateral prefrontal cortex (DLPFC) and improve WM performance.

Who Is on the Research Team?

RS

Ranganatha Sitaram, ME, PhD

Principal Investigator

St. Jude Children's Research Hospital

Are You a Good Fit for This Trial?

This trial is for people who survived childhood medulloblastoma (a type of brain cancer) and now have challenges with attention or memory. Participants should be able to undergo MRI scans and take part in thinking tests.

Inclusion Criteria

English as a primary language
I am between 10 and 25 years old.
I was treated for medulloblastoma with craniospinal radiotherapy at St. Jude at least 2 years ago.
See 1 more

Exclusion Criteria

A psychiatric condition that would preclude or take precedence over study participation (e.g., active psychosis, suicidal ideation)
IQ < 70 based on standardized testing routinely conducted on primary treatment protocols or as part of the New Oncology Program in Psychology (NOPP)
Metal or surgical implants that would prevent MRI scanning
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • rt fMRI Neurofeedback (DLPFC)
  • rt fMRI Neurofeedback (PAC)

Trial Overview

The study tests a new brain training method using real-time neurofeedback from MRI scans. Participants are randomly assigned to get feedback from one of two different brain regions over three sessions, aiming to improve memory and thinking skills.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: DLPFC Neurofeedback GroupExperimental Treatment1 Intervention
Group II: PAC Neurofeedback GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

St. Jude Children's Research Hospital

Lead Sponsor

Trials
451
Recruited
5,326,000+